Study of Safety and Tolerability of Multiple Intravenous Doses of ANZ-521 in Adults With Chronic Hepatitis C Virus
Clinical trial NCT00800007 · TERMINATED
Trial details
- NCT number
- NCT00800007
- Sponsor
- Anza Therapeutics, Inc.
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-11-01
- Primary completion
- 2009-02-01
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.